gestational choriocarcinoma whicli were resistant to eradication bv these drugs with high-dose 68-platinum. All patients had previously received extensive therapy. All therapy was monitored bv twiceweekly radioimmunoassays specific for human chorionic gonadotrophin (hCGP). This assay can detect, down to 2 miu/ml (about equal to 1. ng/ml hCGg in sertim) (Kardana & Bagshawe, 1976) .
68-Platinum is a new anti-cancer agent which has recently been extensively investigated in man (Rozeiicweig et al., 1977; Prestayko et al., 1979) . As far as we are aware, the onlv preliminary reports of the use of ci-8-platinum in gestational choriocarcinoma are from this Centre (Newlands, 1978) and from Amiel et al. (1978) . 
